Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT02019667
Status:
COMPLETED
Last Update Posted:
2020-02-24
First Post:
2013-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-20
First Submit QC Date:
None
Study First Post Date:
2013-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-21
Results First Submit QC Date:
None
Results First Post Date:
2020-02-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-02-24
Last Update Post Date Type:
ACTUAL